Company Overview
Snapshot
Founded in December 2007 by Gallya Gannot and Israel Gannot, Opticul Diagnostics operated with 1–10 employees. The company raised $870,000 across four funding rounds from three investors. In September 2014, BATM invested in Opticul Diagnostics.
Business overview
Opticul Diagnostics was an in vitro diagnostics device company focused on developing easy and low-cost solutions for clinical laboratory and point-of-care microorganism identification. Its core technology, the Optidet device, enabled specific, sensitive, and rapid identification of microorganisms directly from primary culture plates without the need for reagents. The company served the healthcare and life sciences sectors, particularly laboratories, and operated within the Health Tech & Life Sciences industry, specializing in Medical Devices and Diagnostics Devices.
Strategic signal
In September 2014, BATM announced an investment in Opticul Diagnostics, signaling strategic interest in the company's reagent-free microorganism identification technology. This investment highlighted the potential for Opticul's solutions to streamline clinical laboratory processes and point-of-care diagnostics, validating its approach to rapid and cost-effective pathogen detection within the health tech and life sciences market.
Company Intelligence Q&A
- What is Opticul Diagnostics' primary focus?
- Opticul Diagnostics specializes in developing in vitro diagnostic devices for easy and low-cost microorganism identification, primarily for clinical laboratory and point-of-care applications.
- When was Opticul Diagnostics founded and by whom?
- Opticul Diagnostics was founded in December 2007 by Gallya Gannot and Israel Gannot.
- What was the total capital raised by Opticul Diagnostics?
- Opticul Diagnostics raised a total of $870,000 across four funding rounds.
- Which company invested in Opticul Diagnostics in September 2014?
- In September 2014, BATM invested in Opticul Diagnostics.
- What is the status of Opticul Diagnostics?
- Opticul Diagnostics is non-active, having ceased operations in January 2016.